Business
Cytophage Announces Closing of Non-Brokered Private Placement and Filing of Q3 Financials
(TheNewswire) WINNIPEG, November 28 , 2025 — TheNewswire - Cytop...
About this update from Cytophage Technologies Ltd.
[{"type":"text","content":" Cytophage Announces Closing of Non-Brokered Private Placement and Filing of Q3 Financials\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n WINNIPEG, November\n \n\n 28\n \n\n ,\n2025\n \n\n —\n \n\n TheNewswire\n-\n \n\n Cytophage Technologies Ltd. (“\n \n\n Cytophage\n \n\n ” or the\n“\n \n\n Company\n \n\n ”) (TSXV: CYTO, FSE: 70G) today announced that it has\n \n\n now\n \n\n closed the\n \n\n remainder\n \n\n of its\npreviously announced non-brokered private placement (the\n“\n \n\n Offering\n \n\n ”). The full details of the Offering were announced in\n \n\n\n\n a press release dated\nOctober 17, 2025\n \n\n\n\n .  In connection\nwith the closing, the Company raised an\n \n\n additional $198,000 of gross proceeds by issuing a total of\n990,000 Units to investors, to bring the total gross proceeds to\n$1,200,000.\n \n\n\n\n Each Unit\n \n\n , priced at $0.20,\n \n\n consists of one (1) common share of the Company\n(a “Share”) and one half (1/2) of a common share purchase warrant\n(a “Warrant”). Each whole Warrant entitles the holder thereof to\npurchase one (1) additional Share ( a “Warrant Share”) at a price\nof C$0.40 per Warrant Share, for a period of 24 months from the date\nof issuance. Cytophage may accelerate the expiry of the Warrants if\nthe volume weighted average trading price of its Common Shares on the\nTSX Venture Exchange equals or exceed $0.60 for a period of 10\nconsecutive trading days (the “Acceleration Right”). In the event\nthat Cytophage exercises the Acceleration Right it will do so by\nproviding notice to all holders of Warrants.\n \n\n\n\n In connection with the closing, the Company has also\nagreed, subject to receiving Exchange approval, to pay finder’s fees\nof $\n \n\n 4,200\n \n\n in cash and to\n \n\n 21,000\n \n\n broker warrants, on\nthe same terms as the Warrants forming part of the Offering, to\nqualified non related parties. In accordance with the rules and\npolicies of the Exchange and applicable Canadian securities laws, all\nsecurities issued in connection with the closing are subject to a 4\nmonth hold period.\n \n\n\n\n The net proceeds of the Offering will be used by the\nCompany to advance its cutting-edge phage technology in human...